452 related articles for article (PubMed ID: 26500074)
21. Dendritic cell derived-exosomes: biology and clinical implementations.
Chaput N; Flament C; Viaud S; Taieb J; Roux S; Spatz A; André F; LePecq JB; Boussac M; Garin J; Amigorena S; Théry C; Zitvogel L
J Leukoc Biol; 2006 Sep; 80(3):471-8. PubMed ID: 16809645
[TBL] [Abstract][Full Text] [Related]
22. Exosomes-based cell-free cancer therapy: a novel strategy for targeted therapy.
Dutta A
Immunol Med; 2021 Jun; 44(2):116-123. PubMed ID: 32924880
[TBL] [Abstract][Full Text] [Related]
23. Exosomes Function in Tumor Immune Microenvironment.
Huang Y; Liu K; Li Q; Yao Y; Wang Y
Adv Exp Med Biol; 2018; 1056():109-122. PubMed ID: 29754177
[TBL] [Abstract][Full Text] [Related]
24. Personalized medicine and back-allogeneic exosomes for cancer immunotherapy.
Samuel M; Gabrielsson S
J Intern Med; 2021 Feb; 289(2):138-146. PubMed ID: 31359504
[TBL] [Abstract][Full Text] [Related]
25. Emerging Prospects of Exosomes for Cancer Treatment: From Conventional Therapy to Immunotherapy.
Nam GH; Choi Y; Kim GB; Kim S; Kim SA; Kim IS
Adv Mater; 2020 Dec; 32(51):e2002440. PubMed ID: 33015883
[TBL] [Abstract][Full Text] [Related]
26. The Double Face of Exosome-Carried MicroRNAs in Cancer Immunomodulation.
Alfonsi R; Grassi L; Signore M; Bonci D
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652798
[TBL] [Abstract][Full Text] [Related]
27. Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy.
Naseri M; Bozorgmehr M; Zöller M; Ranaei Pirmardan E; Madjd Z
Oncoimmunology; 2020 Jun; 9(1):1779991. PubMed ID: 32934883
[TBL] [Abstract][Full Text] [Related]
28. Tumor-Related Exosomes Contribute to Tumor-Promoting Microenvironment: An Immunological Perspective.
Chen W; Jiang J; Xia W; Huang J
J Immunol Res; 2017; 2017():1073947. PubMed ID: 28642882
[TBL] [Abstract][Full Text] [Related]
29. Dendritic cell-derived exosome (DEX) therapy for digestive system cancers: Recent advances and future prospect.
Al-Hawary SIS; Almajidi YQ; Bansal P; Ahmad I; Kaur H; Hjazi A; Deorari M; Zwamel AH; Hamzah HF; Mohammed BA
Pathol Res Pract; 2024 May; 257():155288. PubMed ID: 38653088
[TBL] [Abstract][Full Text] [Related]
30. Exosomes in Cancer Disease.
Zöller M
Methods Mol Biol; 2016; 1381():111-49. PubMed ID: 26667458
[TBL] [Abstract][Full Text] [Related]
31. Extracellular Vesicles in Oncology: from Immune Suppression to Immunotherapy.
Srivastava A; Rathore S; Munshi A; Ramesh R
AAPS J; 2021 Feb; 23(2):30. PubMed ID: 33586060
[TBL] [Abstract][Full Text] [Related]
32. Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacy.
Rountree RB; Mandl SJ; Nachtwey JM; Dalpozzo K; Do L; Lombardo JR; Schoonmaker PL; Brinkmann K; Dirmeier U; Laus R; Delcayre A
Cancer Res; 2011 Aug; 71(15):5235-44. PubMed ID: 21670078
[TBL] [Abstract][Full Text] [Related]
33. The potential of exosomes in immunotherapy.
Chaput N; Taïeb J; André F; Zitvogel L
Expert Opin Biol Ther; 2005 Jun; 5(6):737-47. PubMed ID: 15952905
[TBL] [Abstract][Full Text] [Related]
34. The application of exosomes as a nanoscale cancer vaccine.
Tan A; De La Peña H; Seifalian AM
Int J Nanomedicine; 2010 Nov; 5():889-900. PubMed ID: 21116329
[TBL] [Abstract][Full Text] [Related]
35. Dexosomes as a cell-free vaccine for cancer immunotherapy.
Nikfarjam S; Rezaie J; Kashanchi F; Jafari R
J Exp Clin Cancer Res; 2020 Nov; 39(1):258. PubMed ID: 33228747
[TBL] [Abstract][Full Text] [Related]
36. Consideration of dual characters of exosomes in the tumour immune response.
Bai J; Xie X; Lei Y; An G; He L; Chen R
Cell Biol Int; 2014 Apr; 38(4):538-45. PubMed ID: 24523154
[TBL] [Abstract][Full Text] [Related]
37. Exosomes derived from Rab27a‑overexpressing tumor cells elicit efficient induction of antitumor immunity.
Li W; Mu D; Tian F; Hu Y; Jiang T; Han Y; Chen J; Han G; Li X
Mol Med Rep; 2013 Dec; 8(6):1876-82. PubMed ID: 24146068
[TBL] [Abstract][Full Text] [Related]
38. Exosome-based immunotherapy: a promising approach for cancer treatment.
Xu Z; Zeng S; Gong Z; Yan Y
Mol Cancer; 2020 Nov; 19(1):160. PubMed ID: 33183286
[TBL] [Abstract][Full Text] [Related]
39. [Exosomes and anti-tumour immunotherapy].
Chaput N; Andre F; Schartz NE; Flament C; Angevin E; Escudier B; Zitvogel L
Bull Cancer; 2003; 90(8-9):695-8. PubMed ID: 14609758
[TBL] [Abstract][Full Text] [Related]
40. Prospects for exosomes in immunotherapy of cancer.
Mignot G; Roux S; Thery C; Ségura E; Zitvogel L
J Cell Mol Med; 2006; 10(2):376-88. PubMed ID: 16796806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
